Quarrell Oliver W J, Nance Martha A, Nopoulos Peggy, Paulsen Jane S, Smith Jonathan A, Squitieri Ferdinando
Department of Clinical Genetics, Sheffield Children's Hospital, Sheffield, UK.
Struthers Parkinson's Center, 6701 Country Club Drive, Golden Valley, MN 55427, USA.
Neurodegener Dis Manag. 2013 Jun 1;3(3). doi: 10.2217/nmt.13.18.
Huntington's disease (HD) is a well-recognized progressive neurodegenerative disorder that follows an autosomal dominant pattern of inheritance. Onset is insidious and can occur at almost any age, but most commonly the diagnosis is made between the ages of 35 and 55 years. Onset ≤20 years of age is classified as juvenile HD (JHD). This age-based definition is arbitrary but remains convenient. There is overlap between the clinical pathological and genetic features seen in JHD and more traditional adult-onset HD. Nonetheless, the frequent predominance of bradykinesia and dystonia early in the course of the illness, more frequent occurrence of epilepsy and myoclonus, more widespread pathology, and larger genetic lesion means that the distinction is still relevant. In addition, the relative rarity of JHD means that the clinician managing the patient is often doing so for the first time. Management is, at best, symptomatic and supportive with few or no evidence-based guidelines. In this article, the authors will review what is known of the condition and present some suggestions based on their experience.
亨廷顿舞蹈病(HD)是一种公认的遵循常染色体显性遗传模式的进行性神经退行性疾病。起病隐匿,几乎可发生于任何年龄,但最常见的诊断年龄在35至55岁之间。发病年龄≤20岁被归类为青少年型亨廷顿舞蹈病(JHD)。这种基于年龄的定义是人为设定的,但仍然很方便。JHD中所见的临床病理和遗传特征与更传统的成年发病型HD之间存在重叠。尽管如此,疾病早期运动迟缓与肌张力障碍更为常见,癫痫和肌阵挛的发生率更高,病理改变更广泛,以及更大的基因病变,意味着这种区分仍然是有意义的。此外,JHD相对罕见,这意味着治疗该患者的临床医生往往是首次遇到这种情况。目前的治疗最多只能是对症和支持治疗,几乎没有基于证据的指南。在本文中,作者将回顾关于这种疾病的已知情况,并根据他们的经验提出一些建议。